Martin Wilson, General Counsel of Rocket Pharmaceuticals, Inc., filed a Form 4 on August 17, 2026, reporting the sale of common stock on August 13, 2026, to cover tax withholding obligations related to the vesting of restricted stock units.

Key Highlights

  • Reporting person: Martin Wilson, General Counsel of Rocket Pharmaceuticals, Inc.
  • Transaction date: August 13, 2026
  • Shares disposed: 3,493 shares of common stock sold at $3.381 per share
  • Purpose: Shares were sold to pay tax withholding obligations in connection with the vesting of RSUs, according to the filing
  • Beneficial ownership following transaction: 674,484 shares held directly, including RSUs that convert to common stock on a one-for-one basis

Wilson's RSU-Related Share Sale at Rocket Pharmaceuticals

According to the Form 4 filed with the SEC on August 17, 2026, Martin Wilson, who serves as General Counsel at Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), disposed of 3,493 shares of common stock on August 13, 2026, at a price of $3.381 per share. The filing carries transaction code "S," indicating a sale in the open market.

The filing states that "the shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs." This type of transaction, sometimes called a "sell-to-cover," is a common mechanism by which employees satisfy tax liabilities triggered by the vesting of equity awards rather than initiating a discretionary market sale.

Following the reported transaction, the filing discloses that Wilson directly holds 674,484 shares of common stock. The filing notes that these holdings include restricted stock units that convert to common stock on a one-for-one basis. No derivative securities transactions were reported in Table II of the filing.

What Was Disclosed

The filing reports a single disposition of 3,493 shares of Rocket Pharmaceuticals common stock by General Counsel Martin Wilson at $3.381 per share on August 13, 2026, attributed solely to tax withholding on RSU vesting, with 674,484 shares remaining directly held.